2018 - Metabolite of stanozolol, 3’‐hydroxystanozolol CAS Arbitrator Upholds Four-Year Sanction
Start
Date
October 17, 2018
End
Date
October 16, 2022
Status
no record
Date of Infraction
October 2, 2018
Event
OOCT
Stirley Jones (M)
athlete, from United States of America, born 1984-12-13, 1 sanction
Notes: CAS Arbitrator Upholds Four-Year Sanction Colorado Springs, Colo. (June 17, 2019) USADA announced today that a three-member panel of the American Arbitration Association (AAA) has rendered a decision in the case of Paralympic track & field athlete Stirley Jones, of San Clemente, Calif., and has determined that Jones should receive a four-year sanction after testing positive for a prohibited substance. Jones, 34, tested positive for a metabolite of stanozolol, 3’‐hydroxystanozolol, as the result of an out-of‐competition urine sample he provided on October 2, 2018. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Paralympic Committee Anti-Doping Code, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. The Panel concluded that Jones did not establish by a balance of probability to the satisfaction of the majority of the Panel that the ingestion of the stanozolol was unintentional. Jones’ four-year period of ineligibility began on October 17, 2018, the date he received a provisional suspension.
